منابع مشابه
Bromocriptine-associated hyponatraemia in cirrhosis.
since the study period. In-vitro tests of thryoid function have become more specific and more available recently and we believe that these should now be included in the routine investigations whenever there is the slightest suspicion that hyperthyroidism or hypothyroidism might account for a patient's presenting bowel disorder. A total of 57% of the surviving patients (18 men and 26 women) stil...
متن کاملShort Communication Irreversible Ototoxicity Associated with Difluoromethylornithine
Difluoromethylornithine (DFMO) is a potent, irreversible inhibitor of ornithine decarboxylase, the ratelimiting enzyme in the synthesis of polyamines that promote cellular proliferation. DFMO has been tested as a potential cancer therapeutic and chemopreventive agent in clinical trials. Reversible hearing loss is a recognized toxicity of DFMO that usually occurs at doses above 2 g/m/d, and gene...
متن کاملOtotoxicity associated with oxaliplatin in a patient with pancreatic cancer.
CONTEXT Oxaliplatin, a third-generation platinum derivative is commonly used for the treatment of colorectal cancer, pancreatic cancer, upper gastrointestinal cancer, hepatobiliary cancer, and ovarian cancer. Neurotoxicity is the dose limiting toxicity and ototoxicity is very rare, less than 1% of patients. CASE REPORT We present a case of a female patient with locally advanced unresectable p...
متن کاملOtotoxicity may be associated with protease inhibitor therapy.
ciency. Pregnant women who have iron deficiency are at higher risk for preterm birth, a low-birth-weight infant, and maternal death, which are factors that must be considered in balancing the potential risks and benefits of iron supplementation during HIV infection [3]. In developed countries, the epidemiology of anemia, nutritional status, and oxidative stress has changed with the advent of hi...
متن کاملCisplatin-Associated Ototoxicity: A Review for the Health Professional
Cisplatin is an effective drug used in the treatment of many cancers, yet its ototoxic potential places cancer patients, exposed to this drug, at risk of hearing loss, thus negatively impacting further on a patient's quality of life. It is paramount for health care practitioners managing such patients to be aware of cisplatin's ototoxic properties and the clinical signs to identify patients at ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of Laryngology & Otology
سال: 1984
ISSN: 0022-2151,1748-5460
DOI: 10.1017/s0022215100146808